Trial intelligence / Profile preview

Naltrexone and Social Experiences

NCT05007561Phase 1Completed

Sponsor
San Diego State University
Start
Nov 2021
Primary completion
Mar 2026
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial comparing Naltrexone with Placebo (2 arms). Primary endpoints: Daily feelings of social connection, Bold Oxygen-level Dependent (BOLD) Activations in Prespecified ROIs at Day 7 and 1 more. Started Nov 2021; status: completed.

02

Drugs

naltrexone

Beyond the preview

Go deeper on NCT05007561.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05007561.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call